Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP778515.RAedwLR_MDJjndJnIhvc6X1--kUV0w_tq_MnbLiPc1bOU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP778515.RAedwLR_MDJjndJnIhvc6X1--kUV0w_tq_MnbLiPc1bOU130_assertion type Assertion NP778515.RAedwLR_MDJjndJnIhvc6X1--kUV0w_tq_MnbLiPc1bOU130_head.
- NP778515.RAedwLR_MDJjndJnIhvc6X1--kUV0w_tq_MnbLiPc1bOU130_assertion description "[RAR?, TMEFF2 and CYGB displayed no apparent methylation, while a combinatory epigenotype based on p16, hTERT, RASSF1 and WT1 was associated with a significantly higher chance of detecting malignancy in any positive sample (odds ratio: 24, 95% CI: 4.7-125, P<0.001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP778515.RAedwLR_MDJjndJnIhvc6X1--kUV0w_tq_MnbLiPc1bOU130_provenance.
- NP778515.RAedwLR_MDJjndJnIhvc6X1--kUV0w_tq_MnbLiPc1bOU130_assertion evidence source_evidence_literature NP778515.RAedwLR_MDJjndJnIhvc6X1--kUV0w_tq_MnbLiPc1bOU130_provenance.
- NP778515.RAedwLR_MDJjndJnIhvc6X1--kUV0w_tq_MnbLiPc1bOU130_assertion SIO_000772 21063414 NP778515.RAedwLR_MDJjndJnIhvc6X1--kUV0w_tq_MnbLiPc1bOU130_provenance.
- NP778515.RAedwLR_MDJjndJnIhvc6X1--kUV0w_tq_MnbLiPc1bOU130_assertion wasDerivedFrom befree-20150227 NP778515.RAedwLR_MDJjndJnIhvc6X1--kUV0w_tq_MnbLiPc1bOU130_provenance.
- NP778515.RAedwLR_MDJjndJnIhvc6X1--kUV0w_tq_MnbLiPc1bOU130_assertion wasGeneratedBy ECO_0000203 NP778515.RAedwLR_MDJjndJnIhvc6X1--kUV0w_tq_MnbLiPc1bOU130_provenance.